Ganguly Siddhartha

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation
    Siddhartha Ganguly
    Blood and Marrow Transplantation Program, University of Kansas Medical Center, Kansas City, KS 66205, USA
    Clin Transplant 26:447-53. 2012
  2. ncbi Burkitt's lymphoma: conversion from lymphoma negative to lymphoma positive status over 2 months in a patient with acquired immunodeficiency syndrome (AIDS)
    Siddhartha Ganguly
    Department of Hematology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Am J Clin Oncol 30:656-7. 2007
  3. ncbi Giant anal condylomatosis after allogeneic bone marrow transplantation: a rare complication of human papilloma virus infection
    N Ganguly
    Department of Medicine, The University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Transpl Infect Dis 10:56-8. 2008
  4. ncbi R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature
    Ganguly Siddhartha
    Division of Hematology Oncology, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA
    J Hematol Oncol 2:14. 2009
  5. ncbi Is there a plateau in the survival curve after autologous transplantation in patients with intermediate and high-risk acute myeloid leukemia? A 20-year single institution experience
    Siddhartha Ganguly
    University of Kansas Medical Center, Kansas City, KS, USA
    Leuk Res 31:1253-7. 2007
  6. ncbi Role of transfusion in stem cell transplantation: a freedom-from-transfusion (FFT), cost and survival analysis
    S Ganguly
    Divisions of Blood and Marrow Transplantation, University of Kansas Medical Center, Kansas City, KS, USA
    J Med Econ 13:55-62. 2010
  7. ncbi Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome
    S Ganguly
    Department of Medicine, University of Kansas Medical Center and Hospital, Kansas City, KS 66160, USA
    Clin Lab Haematol 28:309-12. 2006
  8. ncbi Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach
    N Ganguly
    Department of Pharmacy, University of Kansas Medical Center, Kansas City, Kansas, USA
    Transpl Infect Dis 12:406-11. 2010
  9. ncbi A case of synchronous lymphoplasmacytic lymphoma and rectal carcinoid
    Siddhartha Ganguly
    Division of Hematology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Am J Clin Oncol 29:104-5. 2006
  10. ncbi Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response
    Siddhartha Ganguly
    University of Kansas Medical Center, Kansas City, KS, USA
    Ann Hematol 84:526-31. 2005

Collaborators

Detail Information

Publications18

  1. ncbi Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation
    Siddhartha Ganguly
    Blood and Marrow Transplantation Program, University of Kansas Medical Center, Kansas City, KS 66205, USA
    Clin Transplant 26:447-53. 2012
    ..In conclusion, in this prospective pilot study, prophylactic use of zoledronic acid to prevent early bone loss was found to be safe and feasible in patients with AML undergoing allo-SCT during the immediate post-transplantation period...
  2. ncbi Burkitt's lymphoma: conversion from lymphoma negative to lymphoma positive status over 2 months in a patient with acquired immunodeficiency syndrome (AIDS)
    Siddhartha Ganguly
    Department of Hematology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Am J Clin Oncol 30:656-7. 2007
  3. ncbi Giant anal condylomatosis after allogeneic bone marrow transplantation: a rare complication of human papilloma virus infection
    N Ganguly
    Department of Medicine, The University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Transpl Infect Dis 10:56-8. 2008
    ..The tumor was successfully treated with surgical excision and local application of 5% imiquimod cream...
  4. ncbi R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature
    Ganguly Siddhartha
    Division of Hematology Oncology, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA
    J Hematol Oncol 2:14. 2009
    ..We conducted a meta-analysis of relevant literature comparing the two treatment arms for FL with response being the final endpoint...
  5. ncbi Is there a plateau in the survival curve after autologous transplantation in patients with intermediate and high-risk acute myeloid leukemia? A 20-year single institution experience
    Siddhartha Ganguly
    University of Kansas Medical Center, Kansas City, KS, USA
    Leuk Res 31:1253-7. 2007
    ..2 years. In conclusion, autologous SCT in patients with AML in whom an allogeneic transplantation is not feasible appears to be a safe alternative and a plateau in the survival curve indicates cure in a small proportion of patients...
  6. ncbi Role of transfusion in stem cell transplantation: a freedom-from-transfusion (FFT), cost and survival analysis
    S Ganguly
    Divisions of Blood and Marrow Transplantation, University of Kansas Medical Center, Kansas City, KS, USA
    J Med Econ 13:55-62. 2010
    ..Transfusion of blood products is often necessary for patients undergoing stem cell transplantation (SCT). The need for red cell and platelet transfusion may vary significantly depending on the type of transplantation and underlying disease...
  7. ncbi Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome
    S Ganguly
    Department of Medicine, University of Kansas Medical Center and Hospital, Kansas City, KS 66160, USA
    Clin Lab Haematol 28:309-12. 2006
    ..Closer monitoring of rFVIIa usage, including hematology consultation and enforcement of pre-rFVIIa blood component usage would optimize cost-effectiveness...
  8. ncbi Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach
    N Ganguly
    Department of Pharmacy, University of Kansas Medical Center, Kansas City, Kansas, USA
    Transpl Infect Dis 12:406-11. 2010
    ..In absence of randomized prospective data, an institutional algorithmic protocol removes variance in practice pattern and derives data that may be used for research and improved patient care...
  9. ncbi A case of synchronous lymphoplasmacytic lymphoma and rectal carcinoid
    Siddhartha Ganguly
    Division of Hematology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Am J Clin Oncol 29:104-5. 2006
  10. ncbi Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response
    Siddhartha Ganguly
    University of Kansas Medical Center, Kansas City, KS, USA
    Ann Hematol 84:526-31. 2005
    ..When these results are compared with historical controls or patients treated with other modalities, autologous stem cell transplantation appears to be providing the longest disease-free survival and best duration of response...
  11. ncbi Idiopathic thrombocytopenic purpura associated with bone marrow sea-blue histiocytosis
    Siddhartha Ganguly
    Department of Hematology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Am J Hematol 77:405-6. 2004
  12. ncbi Leukemic phase of follicular lymphoma after treatment with etanercept in a patient with psoriasis
    Siddhartha Ganguly
    Division of Hematology Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA
    Am J Clin Dermatol 10:125-6. 2009
    ..Although the association is intriguing, no causal relationship is suggested...
  13. ncbi Late-onset intestinal perforation in the setting of posttransplantation microangiopathy: a case report
    O S Aljitawi
    Division of Hematology, Blood and Marrow Transplantation, University of Kansas Medical Center, Kansas City, Kansas, USA
    Transplant Proc 42:3892-3. 2010
    ..In our case, the patient poorly responded to treatment secondary to refractory mircoangiopathy...
  14. ncbi Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia
    Siddhartha Ganguly
    Center for Gene and Cell Therapy, Baylor College of Medicine, Houston, Texas 77030, USA
    Am J Hematol 75:48-51. 2004
    ..As there is a wide differential diagnosis for pulmonary infiltrates developing post transplant, TRALI may be under-recognized and should be considered in this setting...
  15. ncbi Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia
    Christopher Stasik
    Department of Pathology and Laboratory Medicine, The University of Kansas Hospital, 3901 Rainbow Boulevard, Kansas City, KS 66100, USA
    Cancer Genet Cytogenet 168:146-9. 2006
    ..3), indicating that this is a lineage switch of the original leukemic clone. To our knowledge, these findings have not been previously reported...
  16. ncbi Chronic myeloid leukemia in accelerated phase with basophilic transformation of the bone marrow
    Mark T Cunningham
    Department of Pathology, University of Kansas Medical Center, Kansas City 66160, USA
    Am J Hematol 81:380-1. 2006
  17. ncbi HAART- and AIDS-related lymphomas
    Jaswinder Singh
    Blood 108:3621; author reply 3621-2. 2006
  18. ncbi Acute intracerebral hemorrhage in intravascular lymphoma: a serious infusion related adverse event of rituximab
    Siddhartha Ganguly
    Division of Hematology, University of Kansas Medical Center, Kansas City, Kansas, USA
    Am J Clin Oncol 30:211-2. 2007